Clin2
NCT07827170Possibly a fitNot yet recruiting

Probiotics with standard H. pylori treatment

Helicobacter Pylori InfectionGastrointestinal DysbiosisAntibiotic-associated Adverse Events

Part of Digestive system, Infections clinical trials.

This study tests whether adding a probiotic (a healthy bacteria supplement) to the standard four-drug treatment for H. pylori infection helps get rid of the bacteria better and with fewer side effects. It may help make your treatment more effective and easier to tolerate.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
336 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be between 18 and 65 years old.
  • You must have a confirmed H. pylori infection (diagnosed by a breath test or a quick stomach test).
  • Your doctor has recommended the standard four-drug bismuth treatment (called 'quadruple therapy') for your H. pylori infection.
  • You must be willing to sign a consent form to participate.
  • You cannot have taken certain medications (like antibiotics, acid reducers, pain relievers, laxatives, anti-diarrhea medicines, or probiotics) in the past 4 weeks.
  • You cannot have serious digestive conditions like bleeding ulcers, inflammatory bowel disease, stomach or colon cancer, or pancreatitis, nor a weakened immune system, alcohol abuse, or be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07139366Recruiting· Phase 4
Probiotic plus bismuth combo for stubborn H. pylori

This study tests a combination of a probiotic (Saccharomyces boulardii) plus a standard bismuth-based four-drug treatment for people whose H. pylori infection has not been cured by previous treatments. It aims to see if adding the probiotic helps the treatment work better and cause fewer side effects.

Xi'an, Shaanxi
NCT06200779Not yet recruiting· Phase 4
Personalized versus standard treatment for H. pylori infection

This study is testing whether giving H. pylori treatment based on the specific bacteria found in your stomach works better than the standard one-size-fits-all approach. If you are already getting an endoscopy with a biopsy, this trial could help find the most effective medication for your infection.

Porto, Porto District
NCT04527055Enrolling by invitation· Phase 4
Bismuth treatment for H. pylori: 10 or 14 days

This trial compares two common stomach medicine plans that use bismuth for 10 days versus 14 days to clear an H. pylori infection. It may help you find a shorter or more effective treatment schedule if you have H. pylori confirmed by an endoscopy.

Tainan
NCT05332444Recruiting· Phase 4
Check if stomach-bacteria testing improves rescue treatment for H. pylori

This study compares two ways to treat Helicobacter pylori (H. pylori) infection that didn’t go away with prior therapy. One approach uses test results to guide which medicines to use, and the other uses standard (“empiric”) treatment. The goal is to see which works better and more safely as a rescue plan.

Taipei
NCT07729293Not yet recruiting
A new add-on treatment for H. pylori infection

This study tests a new treatment called Pylori Duo, used along with standard care, to help get rid of H. pylori bacteria in the stomach and stop it from coming back. It may be a good option if you are newly diagnosed and haven't been treated before.

Don Benito, Badajoz
NCT07439445Recruiting
Simplified treatment for H. pylori guided by a stool test

This trial tests a simpler two-drug treatment for H. pylori infection, chosen based on a stool test that checks if the bacteria are resistant to clarithromycin. It may help people who have not been treated before avoid unnecessary antibiotics.

Beijing, Beijing Municipality

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.